RxDoctor Payments Data

Christopher Rowlett

Podiatrist · Jonesboro, ARNPI 1184756280

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,200 of the $5,783 with a category attached, or 72.6%. 17 manufacturers reported payments, led by Stryker at 38.5% of the total. 2025 is the largest year on record at $2,655, more than ten times the $146 reported in 2019. Among podiatrist clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,783in general payments, 2019–2025

Across 98 payments — averaging $59.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Medtronic$1K
  • Midsouth Orthopedics Inc.$776
  • Arthrex$485
  • Nevro Corp.$456
  • Osiris Therapeutics Inc.$124
  • plus $422 from 11 others
$72,363in research payments, 2019–2025

Across 13 payments — averaging $5566.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Innovation$69K
  • Bristol Myers Squibb$4K

What the payments were for

  • Travel & lodging$1,58327%
  • Food & beverage$4,20073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker47$2,227
Medtronic15$1,294
Midsouth Orthopedics Inc.4$776
Arthrex3$485
Nevro Corp.5$456
Osiris Therapeutics Inc.1$124
Bioventus LLC6$101
Vertex3$75
Amgen4$59
Organogenesis Inc.2$47
Triad Life Sciences Inc.2$40
Acera Surgical, Inc.1$33
Johnson & Johnson1$19
Biowound Solutions, Inc.1$16
Medline Industries LP1$11
Radius Health, Inc.1$11
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,783 in reported general payments places this provider in the 90th percentile of 35 podiatrist providers in Arkansas.

See all podiatrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$151,576
Medicare patients
799
Services billed
3,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin175$2,427
Terbinafine Hcl146$1,224
Allopurinol79$748
Diclofenac Sodium27$743
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$678
Ammonium Lactate17$513
Celecoxib11$277
Clindamycin Hcl24$178
Pregabalin30$173
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$127
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$126

Paid to pharmacies, not to this prescriber.

Other podiatrist in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →